| Entry |
|
|---|
| Name |
Diazepam (JP15/USP/INN);
Diastat (TN);
Valium (TN) |
|---|
| Formula |
C16H13ClN2O
|
|---|
| Mass |
284.0716 |
|---|
| Structure |
     |
|---|
| Target |
GABAA-receptor (benzodiazepine binding site) agonist
[BR:hsa04000] |
|---|
| Metabolism |
CYP2C18 [HSA:1562], CYP2C19 [HSA:1557], CYP3A4 [HSA:1576] |
|---|
| Activity |
Sedative-hypnotic |
|---|
| Remark |
Same as: C06948
Therapeutic category: 1124
ATC code: N05BA01
 |
|---|
| Comment |
Benzodiazepines |
|---|
| Pathway |
PATH: map07030 Anxiolytics
PATH: map07032 Hypnotics
PATH: map07033 Anticonvulsants
PATH: map07117 Benzodiazepine family |
|---|
| Products |
DIAZEPAM (Hospira), DIAZEPAM (Hospira), DIAZEPAM (Qualitest Pharma), DIAZEPAM (USAMRMC), Diastat (Valeant Pharma), Diazepam (Barr Lab), Diazepam (Baxter Healthcare), Diazepam (Hospira), Diazepam (Hospira), Diazepam (Ivax Pharma), Diazepam (Mylan Pharma), Diazepam (Roxane Lab), Diazepam (Watson Lab), VALIUM (Roche Pharma Roche Lab)
|
|
|---|
| Other DBs |
CAS: 439-14-5
PubChem: 7847359
ChEBI: 49575
DrugBank: DB00829
PDB-CCD: DZP
LigandBox: D00293
NIKKAJI: J2.044C |
|---|
| KCF data |
 |
|---|
|
